AFIAS Total Anti-Infliximab
- UID
- IMP/IVD/2021/000365_d92470da30e4d28177b85829f3cbea5f_7f3ea937210318d24889b872b790ddb1
- Device class
- Class B
- Brand name
- AFIAS Infliximab
- License holder
- BODITECH MED INDIA PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- AFIAS Total Anti-Infliximab is a fluorescence Immunoassay (AFIAS Infliximab ) for the semi-quantitative determination of free and bound antibodies against infliximab in human serum/plasma
AFIAS Total Anti-Infliximab is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_d92470da30e4d28177b85829f3cbea5f_7f3ea937210318d24889b872b790ddb1. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.